No article text was recorded for this version.
polypharmacy risks
Version 1 of 143 papers61 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Prevalence of potentially harmful multidrug interactions on medication lists of elderly ambulatory patients
- Blog: Potential Drug Dose‐Specific Adverse Three‐Drug Combinations: A <scp>US</scp> Insurance Claims Data‐Based Study
- Blog: Outpatient prescription drug interactions at a city-affiliated healthcare center in Vietnam
- Blog: Assessing anticancer drug utilization patterns through WHO prescribing indicators at a specialized cancer hospital in Peshawar
- Blog: SEROTONIN SYNDROME INDUCED BY A SINGLE DOSE OF VENLAFAXINE AND MAGNESIUM VALPROATE
- Blog: Predictors and Moderators of Hospitalisation and Mortality in People with Dementia Using Antipsychotics: Systematic Review
- Blog: Research status and hotspots of medication safety in older adults: A bibliometric analysis
- Blog: Chronic diseases spectrum and multimorbidity in elderly inpatients based on a 12-year epidemiological survey in China
- Blog: Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions
- Blog: CausalMed: Causality-Based Personalized Medication Recommendation Centered on Patient Health State
- Blog: Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes
- Blog: A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP)
- Blog: LaGAT: link-aware graph attention network for drug–drug interaction prediction
- Blog: The DynAIRx Project Protocol: Artificial Intelligence for dynamic prescribing optimisation and care integration in multimorbidity
- Blog: DMMS: A Decentralized Blockchain Ledger for the Management of Medication Histories
- Blog: CIDGMed: Causal Inference-Driven Medication Recommendation with Enhanced Dual-Granularity Learning
- Blog: Using natural language processing methods to classify use status of dietary supplements in clinical notes
- Blog: Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database
- Blog: The Challenge of Potential Drug–Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China
- Blog: EDRMM: enhancing drug recommendation via multi-granularity and multi-attribute representation
- Blog: Non-surgical nursing care for tumor patients: an overview of sedation, analgesia, and recent innovations
- Blog: Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database
- Blog: DPDDI: a deep predictor for drug-drug interactions
- Blog: Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning
- Blog: Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study
- Blog: Assessing the extent of drug interactions among patients with multimorbidity in primary and secondary care in the West Midlands (UK): a study protocol for the Mixed Methods Multimorbidity Study (MiMMS)
- Blog: Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system
- Blog: The Use of Phytotherapy in Male Patients with a Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Single Center Study
- Blog: The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective
- Blog: Clinical Efficacy of Traditional Chinese Medicine Orthopedic in the Treatment of Senile Osteoarthritis
- Blog: Multi-view Graph Contrastive Representation Learning for Drug-Drug Interaction Prediction
- Blog: Evaluation of the implementation effect of pre-audit of inpatient medical orders: based on the ORTCC model
- Blog: Atenção odontológica na pessoa idosa: envelhecimento, alterações bucais e desafios na prática clínica
- Blog: Drug-drug interaction prediction based on co-medication patterns and graph matching
- Blog: SimVec: predicting polypharmacy side effects for new drugs
- Blog: The effect of resveratrol on hypertension: A clinical trial
- Blog: DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome
- Blog: Combating antimicrobial resistance: the silent war
- Blog: Med-Tree: A Medical Ontology Tree Combined with the Graph Attention Networks for Medication Recommendation
- Blog: Developing an artificial intelligence method for screening hepatotoxic compounds in traditional Chinese medicine and Western medicine combination
- Blog: Decision Support System for Chronic Diseases Based on Drug-Drug Interactions
- Blog: Conditional Generation Net for Medication Recommendation
- Blog: Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_polypharmacy_risks_1574d4e0,
title = {polypharmacy risks},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/polypharmacy-risks/rdr_1574d4e045b145809705df6825ae1924},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_polypharmacy_risks_1574d4e0_v1,
title = {polypharmacy risks},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/polypharmacy-risks/rdr_1574d4e045b145809705df6825ae1924/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}